Vaccine stands for a preparation of dead, attenuate or else modified viruses, bacteria and other microorganisms utilized as an inoculation to immunize against any disease by way of stimulating antibodies’ production. With constant technology upgrades and launches of new medicinal products, Vaccines proved to be the most sophisticated healthcare aid ever created in the pharma’s history.
The global Vaccine Industry is thriving mainly owing to the chronic availability of different diseases, both already-existing and cropping up on the horizon, which can be luckily prevented with Vaccines’ assistance. Pediatric Vaccines form the largest and the most hastily evolving segment as against adult Vaccines, with the trend predicted to stay unaltered in the impending period. The worldwide Vaccine Market is primarily in the paws of such behemoths as Merck & Company, Inc.; Novartis, Pfizer, Inc.; GlaxoSmithKline plc; and Sanofi Pasteur.
The research reports under this Catalogue provide in-depth assessments of the global Vaccine Industry, discussing pressing market issues and statistical figures. The research reports cover the sizing (value/volume) and short-to-long-run forecasts for the overall Vaccine Market and its major segments, and for numerous geographic markets. The listing of M&As among the Vaccine universe participants with new products’ reviews, alongside company profile information can be derived from the research reports too.
Publications found:
882
Sort by:
Meningococcal Vaccines Market Size, Share and Growth Outlook 2026: By Product Type (Bivalent, Quadrivalent, Pentavalent, Others), By Vaccine Type, By Age Group, By Sales Channel, By Brand, Companies to 2034.
US$ 3,482.00
The global Meningococcal Vaccines Market size is forecast to increase from $4.53 Billion in 2026 to $6.52 Billion in 2034 at a CAGR of 4.66% between 2026 and 2034. The Meningococcal Vaccines market re...
July 2026
190 pages
SGLT2 Inhibitors Market Size, Share and Growth Outlook 2026: By Drug Molecule (Canagliflozin, Dapagliflozin, Empagliflozin, Ertugliflozin, Ipragliflozin, Sotagliflozin, Others), By Therapeutic Indication, By Distribution Channel, Companies to 2034.
US$ 3,482.00
The global SGLT2 Inhibitors Market size is forecast to increase from $27.98 Billion in 2026 to $50.27 Billion in 2034 at a CAGR of 7.6% between 2026 and 2034. The SGLT2 Inhibitors market report provid...
July 2026
190 pages
South Korea Vaccine Market Report by Product Type (Multivalent Vaccine, Monovalent Vaccine), Treatment Type (Preventive Vaccine, Therapeutic Vaccine), Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others), Route of Administration (Intramuscular and Subcutaneous Administration, Oral Administration, and Others), Patient Type (Pediatric, Adult), Indication (Bacterial Diseases, Viral Diseases), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales, and Others), End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, and Others), and Region 2026-2034
US$ 2,999.00
South Korea vaccine market size reached USD 1,185.1 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,648.7 Million by 2034, exhibiting a growth rate (CAGR) of 3.74% duri...
July 2026
118 pages
Combination Vaccines Market - 2026-2033
US$ 3,400.00
Combination Vaccines Market reached USD 6.03 Billion in 2025 and is expected to reach USD 12.9 Billion by 2033, growing with a CAGR of 10.60% during the forecast period 2026-2033. The Combination Vacc...
June 2026
46 pages
Vaccine Adjuvants Market Size, Share, Trends and Forecast by Product Type, Route of Administration, Diseases, Application, and Region, 2026-2034
US$ 2,999.00
The global vaccine adjuvants market size reached USD 1,223.6 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 2,987.6 Million by 2034, exhibiting a growth rate (CAGR) of 1...
June 2026
136 pages
Mexico Vaccine Market Report by Product Type (Multivalent Vaccine, Monovalent Vaccine),Treatment Type (Preventive Vaccine, Therapeutic Vaccine), Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others), Route of Administration (Intramuscular and Subcutaneous Administration, Oral Administration, and Others), Patient Type (Pediatric, Adult), Indication (Bacterial Diseases, Viral Diseases), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales, and Others), End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, and Others), and Region 2026-2034
US$ 2,999.00
Mexico vaccine market size reached USD 1.2 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 1.9 Billion by 2034, exhibiting a growth rate (CAGR) of 5.45% during 2026-2034....
June 2026
121 pages
Human DNA Vaccine Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Route of Administration (Intramuscular, Subcutaneous, Intradermal, Others), By Application (Oncology, Tuberculosis, HIV, Others), By End User (Hospitals & Clinics, Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Human DNA Vaccine Market is projected for substantial growth, expanding from USD 371.02 Million in 2025 to USD 581.28 Million by 2031, demonstrating a CAGR of 7.77%. These advanced immunizi...
May 2026
189 pages
Bacterial Vaccines Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Vaccine Type (Pertussis (Whooping Cough) Vaccines, Tetanus Vaccines, Diphtheria Vaccines, Pneumococcal Vaccines, Meningococcal Vaccines, Typhoid Vaccines, Tuberculosis (TB) Vaccines, Cholera Vaccines, Shigellosis Vaccines, Others), By Patient Age Group (Pediatric Vaccines (Infants, Children), Adolescent Vaccines, Adult Vaccines, Geriatric Vaccines), By Distribution Channel (Government Agencies and Programs, Hospitals and Clinics, Retail Pharmacies, Online Pharmacies, Others) , By Route of Administration (Injectable Vaccines, Oral Vaccines, Nasal Vaccines), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Bacterial Vaccines Market is projected to expand from USD 7.19 billion in 2025 to USD 10.94 billion by 2031, achieving a 7.25% CAGR. Bacterial vaccines are biological agents designed to sti...
May 2026
185 pages
Nasal Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Subunit, Recombinant, and Conjugate Vaccines, Others), By Application (Influenza, COVID-19, Others (such as Cholera, Typhoid, etc.)), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Nasal Vaccines Market is projected to expand significantly, growing from USD 434.21 Million in 2025 to USD 623.29 Million by 2031, at a Compound Annual Growth Rate of 6.21%. These vaccines...
May 2026
180 pages
Pneumococcal Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Conjugate Vaccines, Polysaccharide Vaccines), By Indication (Bronchitis, Meningitis, Pneumonia, Sepsis), By Product (Pneumovax23, Prevnar 13, Synflorix), By Distribution (Government Authorities, Non-Governmental Organizations), By Region & Competition, 2021-2031F
US$ 4,500.00
The global pneumococcal vaccine market is projected to expand significantly, from USD 9.71 billion in 2025 to USD 13.98 billion by 2031, demonstrating a compound annual growth rate (CAGR) of 6.26%. Th...
May 2026
185 pages
Vaccine Adjuvants Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Adjuvant Emulsions, Pathogen Components, Saponin-Based Adjuvants, Particulate Adjuvants, Other Adjuvants), By Type (Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants), By Application (Research Applications, Commercial Applications), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Vaccine Adjuvants Market is projected to expand significantly, rising from USD 0.83 Billion in 2025 to USD 1.22 Billion by 2031, at a Compound Annual Growth Rate (CAGR) of 6.63%. Vaccine ad...
May 2026
180 pages
BCG Vaccines Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Immune BCG, Therapy BCG), By Application (Tuberculosis, Bladder Cancer), By Distribution Channel (Hospitals, Clinics, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global BCG Vaccines Market is projected to expand robustly, growing from USD 149.71 Million in 2025 to USD 212.01 Million by 2031, at a compound annual growth rate of 5.97%. The Bacillus Calmette-...
May 2026
180 pages
H1N1 Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Route of Administration (Intradermal Vaccines, Intramuscular Vaccines, Intranasal Vaccines), By Type of Brand (Agripal, Fiuarix, Influgen, Influvac, Nasovac, Vaxigrip), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global H1N1 Vaccines Market is projected to expand from USD 10.13 billion in 2025 to USD 13.07 billion by 2031, demonstrating a compound annual growth rate of 4.34%. These vaccines, typically foun...
May 2026
185 pages
Cholera Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Whole cell V. Cholerae O1 Recombinant With B-Subunit and Killed Oral O1 & O139), By Product (Vaxchora, Dukoral, Shanchol, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global cholera vaccines market is projected to expand significantly, growing from USD 97.32 Million in 2025 to USD 166.11 Million by 2031 at a 9.32% CAGR. These biological preparations, primarily...
May 2026
180 pages
Measles, Mumps, Rubella Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Monovalent, Trivalent (combined MMR), Tetravalent), By Targeted Population (Infants and children (9 months to 12), Adults), By Distribution Channel (Hospitals and Healthcare Institutions, Vaccine Centers and Public Health Clinics, Pediatric and Private Healthcare Clinics), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Measles, Mumps, Rubella (MMR) Vaccine Market is projected to expand significantly, rising from USD 2.19 Billion in 2025 to USD 3.65 Billion by 2031, demonstrating an 8.89% Compound Annual G...
May 2026
189 pages
Global Consumption Type Vaccine Market Growth 2026-2032
US$ 3,660.00
The global Consumption Type Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. The driving factors of Con...
May 2026
110 pages
Global Seasonal Vaccines Market Growth 2026-2032
US$ 3,660.00
The global Seasonal Vaccines market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. The driving factors for seasonal...
May 2026
110 pages
